We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$145M
2
TSM icon
TSMC
TSM
+$120M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$37.4M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$9.96M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$322M
2
MSFT icon
Microsoft
MSFT
+$269M
3
AMZN icon
Amazon
AMZN
+$128M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$107M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$80.6M

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIC
3651
DELISTED
Retail Opportunity Investments Corp.
ROIC
$13K ﹤0.01%
862
-14,489
-94% -$212K
AE
3652
DELISTED
Adams Resources & Energy Inc
AE
$13K ﹤0.01%
+343
New +$12.5K
SBOW
3653
DELISTED
SilverBow Resources, Inc.
SBOW
$13K ﹤0.01%
474
-4,557
-91% -$144K
TCON
3654
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$13K ﹤0.01%
426
+84
+25% +$2.54K
ENG
3655
DELISTED
ENGlobal Corp
ENG
$13K ﹤0.01%
2,156
-53
-2% -$412
CBAY
3656
DELISTED
Cymabay Therapeutics
CBAY
$13K ﹤0.01%
2,057
-4,470
-68% -$17K
PNT
3657
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$13K ﹤0.01%
1,741
-9,142
-84% -$67.8K
EMAN
3658
DELISTED
eMagin Corporation
EMAN
$13K ﹤0.01%
14,858
-5,605
-27% -$4.61K
THRN
3659
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$13K ﹤0.01%
3,502
+738
+27% +$3.27K
DICE
3660
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$13K ﹤0.01%
448
-790
-64% -$25.8K
ELVT
3661
DELISTED
Elevate Credit, Inc.
ELVT
$13K ﹤0.01%
7,584
-4,727
-38% -$6.56K
MSAC
3662
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$13K ﹤0.01%
1,312
-7
-0.5% -$70
MMX
3663
DELISTED
Maverix Metals Inc. Common Shares
MMX
$13K ﹤0.01%
2,668
-170
-6% -$656
PACX
3664
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$13K ﹤0.01%
1,367
-751
-35% -$7.54K
MFGP
3665
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$13K ﹤0.01%
2,026
+3
+0.1% +$18
PFSW
3666
DELISTED
PFSweb, Inc.
PFSW
$13K ﹤0.01%
2,023
-439
-18% -$4.1K
ACXP icon
3667
Acurx Pharmaceuticals
ACXP
$6.02M
$12K ﹤0.01%
145
– –
ADAP
3668
DELISTED
Adaptimmune Therapeutics
ADAP
$12K ﹤0.01%
7,988
-21,882
-73% -$35.4K
AEYE icon
3669
AudioEye
AEYE
$99.8M
$12K ﹤0.01%
3,319
+1,026
+45% +$5.09K
AMPG icon
3670
AmpliTech
AMPG
$101M
$12K ﹤0.01%
5,787
+1,554
+37% +$3.43K
AMRC icon
3671
Ameresco
AMRC
$1.48B
$12K ﹤0.01%
211
-3,487
-94% -$212K
ANIP icon
3672
ANI Pharmaceuticals
ANIP
$1.76B
$12K ﹤0.01%
290
-2,523
-90% -$94.8K
ARL icon
3673
American Realty Investors
ARL
$242M
$12K ﹤0.01%
451
-211
-32% -$4.23K
ARTW icon
3674
Arts-Way Manufacturing Co
ARTW
$16.2M
$12K ﹤0.01%
6,494
-1,643
-20% -$3.27K
AVAH icon
3675
Aveanna Healthcare
AVAH
$2.68B
$12K ﹤0.01%
15,147
-26,007
-63% -$27.2K
145 146
147
148 149

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.